日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Homologous recombination deficiency and hemizygosity drive resistance in breast cancer

同源重组缺陷和半合子状态是乳腺癌耐药性的驱动因素

Safonov, Anton; Lee, Minna; Brown, David N; Boscolo Bielo, Luca; Mehine, Miika; Bandlamudi, Chaitanya; O'Leary, Ben; Shao, Hong; Vicente, Laia; Muldoon, Daniel; Zhu, Allen; Ros, Susana; Marra, Antonio; Selenica, Pier; Bieche, Ivan; Wubbenhorst, Bradley; Ferraro, Emanuela; Courtois, Laura; El Botty, Rania; Ahmed, Mehnaj; Moiso, Enrico; An, Julia Ah-Reum; Donoghue, Mark T A; Will, Marie; Pareja, Fresia; Nizialek, Emily; Lukashchuk, Natalia; Sofianopoulou, Eleni; Liu, Yuan; Huang, Xin; Chappey, Colombe; Staniszewska, Anna D; Ross, Dara; Mandelker, Diana; Ladanyi, Marc; Schultz, Nikolaus; Berger, Michael F; Scaltriti, Maurizio; Reis-Filho, Jorge S; Li, Bob T; Offit, Kenneth; Norton, Larry; Shen, Ronglai; Maxwell, Kara N; Couch, Fergus; Domchek, Susan M; Marangoni, Elisabetta; Shah, Sohrab; Albertella, Mark R; Serra, Violeta; Weigelt, Britta; Solit, David B; Nathanson, Katherine L; Robson, Mark E; Turner, Nicholas C; Chandarlapaty, Sarat; Razavi, Pedram

Targeting PRMTs Creates Vulnerability of DNA Double-Stand Break Repair Pathways, and Potentiates Chemotherapy Efficacy in TNBC

靶向PRMTs可破坏DNA双链断裂修复通路,并增强TNBC的化疗疗效。

Thiebaut, Charlène; Martinez, Sébastien; Pruvost, Ludivine; Eve, Louisane; El-Botty, Rania; Sourd, Laura; Montaudon, Elodie; Dahmani, Ahmed; Derrien, Heloise; Sentis, Stéphanie; Poulard, Coralie; Marangoni, Elisabetta; Trédan, Olivier; Le Romancer, Muriel

Acetalax and Bisacodyl for the Treatment of Triple-Negative Breast Cancer: A Combined Molecular and Preclinical Study

Acetalax 和 Bisacodyl 治疗三阴性乳腺癌:一项综合分子和临床前研究

William C Reinhold #, Elisabetta Marangoni #, Fathi Elloumi, Remi Montagne, Sudhir Varma, Yanghsin Wang, Keyvan Rezai, Ludivine Morriset, Ahmed Dahmani, Rania El Botty, Léa Huguet, Makito Mizunuma, Naoko Takebe, Samuel Huguet, Augustin Luna, Yves Pommier

Targeting Transcriptional Regulation with a CDK9 Inhibitor Suppresses Growth of Endocrine- and Palbociclib-Resistant ER+ Breast Cancers

使用 CDK9 抑制剂靶向转录调控可抑制内分泌和哌柏西利耐药 ER+ 乳腺癌的生长

Arany Soosainathan, Marjan Iravani, Rania El-Botty, John Alexander, Laura Sourd, Ludivine Morisset, Pierre Painsec, Rebecca Orha, Joanna Nikitorowicz-Buniak, Sunil Pancholi, Syed Haider, Mitch Dowsett, Elisabetta Marangoni, Lesley-Ann Martin, Clare M Isacke

Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy and palbociclib resistant metastatic breast cancers

氧化磷酸化是内分泌治疗和哌柏西利耐药转移性乳腺癌的代谢脆弱性

Rania El-Botty, Ludivine Morriset, Elodie Montaudon, Zakia Tariq, Anne Schnitzler, Marina Bacci, Nicla Lorito, Laura Sourd, Léa Huguet, Ahmed Dahmani, Pierre Painsec, Heloise Derrien, Sophie Vacher, Julien Masliah-Planchon, Virginie Raynal, Sylvain Baulande, Thibaut Larcher, Anne Vincent-Salomon, Gu

Homologous recombination deficiency derived from whole-genome sequencing predicts platinum response in triple-negative breast cancers

全基因组测序得出的同源重组缺陷可预测三阴性乳腺癌的铂类治疗反应

Petra Ter Brugge, Sarah C Moser, Ivan Bièche, Petra Kristel, Sabrina Ibadioune, Alexandre Eeckhoutte, Roebi de Bruijn, Eline van der Burg, Catrin Lutz, Stefano Annunziato, Julian de Ruiter, Julien Masliah Planchon, Sophie Vacher, Laura Courtois, Rania El-Botty, Ahmed Dahmani, Elodie Montaudon, Ludiv

HORMAD1 overexpression predicts response to anthracycline-cyclophosphamide and survival in triple-negative breast cancers

HORMAD1 过表达可预测三阴性乳腺癌对蒽环类-环磷酰胺的疗效和生存率

Rania El-Botty, Sophie Vacher, Juliette Mainguené, Adrien Briaux, Sabrina Ibadioune, Ahmed Dahmani, Elodie Montaudon, Fariba Nemati, Léa Huguet, Laura Sourd, Ludivine Morriset, Sophie Château-Joubert, Thierry Dubois, Virginie Maire, Rosette Lidereau, Audrey Rapinat, David Gentien, Florence Coussy, I

In vivo efficacy assessment of the CDK4/6 inhibitor palbociclib and the PLK1 inhibitor volasertib in human chordoma xenografts

CDK4/6抑制剂帕博西尼和PLK1抑制剂沃拉塞替在人脊索瘤异种移植模型中的体内疗效评估

Passeri, Thibault; Dahmani, Ahmed; Masliah-Planchon, Julien; El Botty, Rania; Courtois, Laura; Vacher, Sophie; Marangoni, Elisabetta; Nemati, Fariba; Roman-Roman, Sergio; Adle-Biassette, Homa; Mammar, Hamid; Froelich, Sébastien; Bièche, Ivan; Decaudin, Didier

Dramatic In Vivo Efficacy of the EZH2-Inhibitor Tazemetostat in PBRM1-Mutated Human Chordoma Xenograft

EZH2 抑制剂 Tazemetostat 在 PBRM1 突变的人类脊索瘤异种移植中的体内疗效显著

Thibault Passeri, Ahmed Dahmani, Julien Masliah-Planchon, Adnan Naguez, Marine Michou, Rania El Botty, Sophie Vacher, Rachida Bouarich, André Nicolas, Marc Polivka, Coralie Franck, Anne Schnitzler, Fariba Némati, Sergio Roman-Roman, Franck Bourdeaut, Homa Adle-Biassette, Hamid Mammar, Sébastien Froe

HRAS is a therapeutic target in malignant chemo-resistant adenomyoepithelioma of the breast

HRAS是乳腺恶性化疗耐药性腺肌上皮瘤的治疗靶点。

Bièche, Ivan; Coussy, Florence; El-Botty, Rania; Vacher, Sophie; Château-Joubert, Sophie; Dahmani, Ahmed; Montaudon, Elodie; Reyes, Cécile; Gentien, David; Reyal, Fabien; Ricci, Francesco; Nicolas, André; Marchio, Caterina; Vincent-Salomon, Anne; Laé, Marick; Marangoni, Elisabetta